Literature DB >> 14764748

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.

Harold Bays1, Lawrence Mandarino, Ralph A DeFronzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14764748     DOI： 10.1210/jc.2003-030723

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  156 in total

1.  Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart.

Authors:  ZhengLong Liu; Jeffrey Ding; Timothy S McMillen; Outi Villet; Rong Tian; Dan Shao
Journal:  J Mol Cell Cardiol       Date:  2020-06-24       Impact factor: 5.000

2.  Irbesartan treatment up-regulates hepatic expression of PPARalpha and its target genes in obese Koletsky (fa(k)/fa(k)) rats: a link to amelioration of hypertriglyceridaemia.

Authors:  X Rong; Y Li; K Ebihara; M Zhao; T Kusakabe; T Tomita; M Murray; K Nakao
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.

Authors:  Eric P Davidson; Lawrence J Coppey; Nigel A Calcutt; Christine L Oltman; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

Review 4.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

5.  Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts.

Authors:  Anthony M Vertino; Jane M Taylor-Jones; Kenneth A Longo; Edward D Bearden; Timothy F Lane; Robert E McGehee; Ormond A MacDougald; Charlotte A Peterson
Journal:  Mol Biol Cell       Date:  2005-01-26       Impact factor: 4.138

6.  Acute modulation of adipose tissue lipolysis by intravenous estrogens.

Authors:  Rachael E Van Pelt; Wendolyn S Gozansky; Robert C Hickner; Robert S Schwartz; Wendy M Kohrt
Journal:  Obesity (Silver Spring)       Date:  2006-12       Impact factor: 5.002

7.  Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk.

Authors:  Harold Bays; Helena W Rodbard; Alan Bruce Schorr; J Michael González-Campoy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 8.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

9.  Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes.

Authors:  L Xi; Z Qian; G Xu; C Zhou; S Sun
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

10.  Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels.

Authors:  Ellen W Demerath; Derek Reed; Nikki Rogers; Shumei S Sun; Miryoung Lee; Audrey C Choh; William Couch; Stefan A Czerwinski; W Cameron Chumlea; Roger M Siervogel; Bradford Towne
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.